Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jean-Marc Rolain and Philippe Brouqui.
Jean-Marc Rolain
Connection Strength
0.679
Philippe Brouqui
  1. A new strategy to fight antimicrobial resistance: the revival of old antibiotics. Front Microbiol. 2014; 5:551.
    View in: PubMed
    Score: 0.150
  2. Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity. Microb Drug Resist. 2021 Mar; 27(3):281-290.
    View in: PubMed
    Score: 0.058
  3. Low blood zinc concentrations in patients with poor clinical outcome during SARS-CoV-2 infection: is there a need to supplement with zinc COVID-19 patients? J Microbiol Immunol Infect. 2021 Oct; 54(5):997-1000.
    View in: PubMed
    Score: 0.058
  4. Natural history of COVID-19 and therapeutic options. Expert Rev Clin Immunol. 2020 12; 16(12):1159-1184.
    View in: PubMed
    Score: 0.058
  5. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. 2020 Jul - Aug; 36:101791.
    View in: PubMed
    Score: 0.056
  6. Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world. New Microbes New Infect. 2020 Nov; 38:100709.
    View in: PubMed
    Score: 0.055
  7. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May - Jun; 35:101738.
    View in: PubMed
    Score: 0.055
  8. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020 Mar - Apr; 34:101663.
    View in: PubMed
    Score: 0.055
  9. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul; 56(1):105949.
    View in: PubMed
    Score: 0.055
  10. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020 04; 55(4):105932.
    View in: PubMed
    Score: 0.054
  11. Rickettsia slovaca and R. raoultii in tick-borne Rickettsioses. Emerg Infect Dis. 2009 Jul; 15(7):1105-8.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.